Cadila Pharma launches Posaconazole to treat fungal diseases EP News Bureau Jun 21, 2021 National Task Force on COVID-19 has recommended Posaconazole, for the treatment of Mucormycosis
MSN Laboratories launches Posaconazole to treat mucormycosis EP News Bureau May 22, 2021 MSN has launched the product under the brand name PosaOne as 100 mg Delayed-Release tablets and 300 mg injections, respectively
